{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:25:15Z","timestamp":1767666315859},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1987,8,1]],"date-time":"1987-08-01T00:00:00Z","timestamp":554774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1987,8]]},"DOI":"10.1007\/bf02455985","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T20:44:11Z","timestamp":1154292251000},"page":"539-548","source":"Crossref","is-referenced-by-count":16,"title":["A comparison of nine calcium ion antagonists and propranolol: Exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris"],"prefix":"10.1007","volume":"32","author":[{"given":"N. S.","family":"Khurmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. B.","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02455985_CR1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.CIR.62.4.669","volume":"62","author":"C Ellrodt","year":"1980","unstructured":"Ellrodt C, Chew CYC, Singh BN (1980) Therapeutic implications of slow channel blockade in cardiocirculatory disorders. Circulation 62: 669\u2013679","journal-title":"Circulation"},{"key":"BF02455985_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","volume":"17","author":"A Fleckenstein","year":"1977","unstructured":"Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17: 149\u2013166","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BF02455985_CR3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-94-1-124","volume":"94","author":"R Zelis","year":"1981","unstructured":"Zelis R, Flaim SF (1981) Calcium influx blockers and vascular smooth muscle: do we really understand the mechanisms? Ann Intern Med 94: 124\u2013126","journal-title":"Ann Intern Med"},{"key":"BF02455985_CR4","first-page":"5","volume-title":"Calcium antagonism in cardiovascular therapy. Experience with verapamil","author":"L Schamroth","year":"1981","unstructured":"Schamroth L (1981) The philosphy of calcium ion antagonists. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy. Experience with verapamil. Excerpta Medica, Amsterdam, pp 5\u20139"},{"key":"BF02455985_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.me.33.020182.002341","volume":"33","author":"R Zelis","year":"1982","unstructured":"Zelis R, Flaim SF (1982) Calcium blocking drugs for angina pectoris. Ann Rev Med 33: 465\u2013478","journal-title":"Ann Rev Med"},{"key":"BF02455985_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0735-1097(83)80035-7","volume":"1","author":"DM Krikler","year":"1983","unstructured":"Krikler DM, Rowland E (1983) Clinical value of calcium antagonists in treatment of cardiovascular disorders. J. Am Coll Cardiol 1: 355\u2013364","journal-title":"J. Am Coll Cardiol"},{"key":"BF02455985_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/pgmj.50.585.447","volume":"50","author":"DM Krikler","year":"1974","unstructured":"Krikler DM, Spurrel RAJ (1974) Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgrad Med J 50: 447\u2013453","journal-title":"Postgrad Med J"},{"key":"BF02455985_CR8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.CIR.60.6.1208","volume":"60","author":"DR Rosing","year":"1979","unstructured":"Rosing DR, Kent KM, Maron, BJ, Epstein SE (1979) Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 60: 1208\u20131213","journal-title":"Circulation"},{"key":"BF02455985_CR9","first-page":"353","volume-title":"Calcium antagonism in cardiovascular therapy. Experience with verapamil","author":"R Hopf","year":"1981","unstructured":"Hopf R, Kaltenbach M, Kober G (1981) Verapamil in the treatment of hypertrophic obstructive cardiomyopathy. In: Zanchetti A, Krikler DM, (eds) Calcium antagonism in cardiovascular therapy. Experience with verapamil. Excerpta Medica, Amsterdam, pp 353\u2013362"},{"key":"BF02455985_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.65.1.22","volume":"65","author":"BA Gould","year":"1982","unstructured":"Gould BA, Mann S, Kieso H, Subramanian VB, Raftery EB (1982) The 24-hour ambulatory blood pressure profile with verapamil. Circulation 65: 22\u201327","journal-title":"Circulation"},{"key":"BF02455985_CR11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9149(83)90306-5","volume":"51","author":"RS Hornung","year":"1983","unstructured":"Hornung RS, Gould BA, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intra-arterial recording. Am J Cardiol 51: 1323\u20131327","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004872-198306000-00014","volume":"1","author":"RI Jones","year":"1983","unstructured":"Jones RI, Hornung RS, Sonecha TN, Raftery EB (1983) The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise. J Hypertens 1: 85\u201389","journal-title":"J Hypertens"},{"key":"BF02455985_CR13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0002-9149(79)90201-7","volume":"44","author":"S Goldberg","year":"1979","unstructured":"Goldberg S, Reichek N, Wilson J, Hirshfield JWJ, Muller J, Kastor JA (1979) Nifedipine in the treatment of Prinzmetal's (variant) angina. Am J Cardiol 44: 804\u2013810","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0002-9149(80)90062-4","volume":"46","author":"S Severi","year":"1980","unstructured":"Severi S, Davies GJ, Maseri A, Marzullo P, L'Abbate A (1980) Long-term prognosis of \u2018variant\u2019 angina with medical treatment. Am J Cardiol 46: 226\u2013232","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0002-8703(83)90043-1","volume":"106","author":"CJ Pepine","year":"1983","unstructured":"Pepine CJ, Feldman RL, Hill JA, Conti CR, Mehta J, Hill C, Scott E, Gainesville RN (1983) Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine and verapamil. Am Heart J 106: 1341\u20131347","journal-title":"Am Heart J"},{"key":"BF02455985_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9149(85)90840-9","volume":"56","author":"JS Gelman","year":"1985","unstructured":"Gelman JS, Feldman RL, Scott E, Pepine CJ (1985) Nicardipine for angina pectoris at rest and coronary arterial spasm. Am J Cardiol 56: 232\u2013236","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1378\/chest.79.3.302","volume":"79","author":"R Corbalan","year":"1981","unstructured":"Corbalan R, Gonzalez R, Chamono G, Munoz M, Rodriquez JA, Casanegra P (1981) Effect of calcium inhibitor nifedipine, on exercise tolerance in patients with angina pectoris. Chest 79: 302\u2013305","journal-title":"Chest"},{"key":"BF02455985_CR18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0735-1097(83)80339-8","volume":"2","author":"BS Lindenberg","year":"1983","unstructured":"Lindenberg BS, Weiner DA, McCabe CH, Cutler SS, Ryan TJ, Klein MD (1983) Efficacy and safety of increamental doses of diltiazem for the treatment of stable angina pectoris. J Am Coll Cardiol 2: 1129\u20131133","journal-title":"J Am Coll Cardiol"},{"key":"BF02455985_CR19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0002-9149(80)90366-5","volume":"46","author":"PD Henry","year":"1980","unstructured":"Henry PD (1980) Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem. Am J Cardiol 46: 1047\u20131058","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(80)91303-3","volume":"1","author":"LH Opie","year":"1980","unstructured":"Opie LH (1980) Drugs and the heart III. Calcium antagonists. Lancet 1: 806\u2013809","journal-title":"Lancet"},{"key":"BF02455985_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1983.tb09403.x","volume":"78","author":"RP Hof","year":"1983","unstructured":"Hof RP (1983) Calcium antagonist and the peripheral circulation: Differences and similarities between PY-108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol 78: 375\u2013394","journal-title":"Br J Pharmacol"},{"key":"BF02455985_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0033-0620(69)90027-9","volume":"11","author":"RA Bruce","year":"1969","unstructured":"Bruce RA, Hornsten TR (1969) Exercise stress testing in evaluation of patients with ischaemic heart disease. Progr Cardiovasc Dis 11: 371\u2013390","journal-title":"Progr Cardiovasc Dis"},{"key":"BF02455985_CR23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","volume":"54","author":"L Campeau","year":"1976","unstructured":"Campeau L (1976) Grading of angina pectoris (letter). Circulation 54: 522\u2013523","journal-title":"Circulation"},{"key":"BF02455985_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5273(84)90346-2","volume":"6","author":"NS Khurmi","year":"1984","unstructured":"Khurmi NS, Bowles MJ, O'Hara MJ, Robinson CW, Raftery EB (1984) Reproducibility of multistage graded exercise testing in patients with chronic stable angina. Int J Cardiol 6: 137\u2013146","journal-title":"Int J Cardiol"},{"key":"BF02455985_CR25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9149(86)90728-9","volume":"57","author":"NS Khurmi","year":"1986","unstructured":"Khurmi NS, Bowles MJ, Kohli RS, Raftery EB (1986) Does placebo improve indexes of effort-induced myocardial ischemia? An objective study in 150 patients with chronic stable angina pectoris. Am J Cardiol 57: 907\u2013911","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/clc.4960091005","volume":"9","author":"NS Khurmi","year":"1986","unstructured":"Khurmi NS, Bowles MJ, Raftery EB (1986) Are anti-platelet drugs of value in the management of patients with chronic stable angina? A study with Ticlopidine. Clin Cardiol 9: 493\u2013498","journal-title":"Clin Cardiol"},{"key":"BF02455985_CR27","first-page":"421A","volume":"58","author":"MH Ellestad","year":"1979","unstructured":"Ellestad MH, Blomqvist CG, Naughton JP (1979) Standards for adult exercise testing laboratories. Circulation 58: 421A-430A","journal-title":"Circulation"},{"key":"BF02455985_CR28","first-page":"75","volume-title":"Statistical methods","author":"GW Snedecor","year":"1967","unstructured":"Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Ames, Iowa, pp 75\u201377"},{"key":"BF02455985_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-75-2-263","volume":"75","author":"SE Epstein","year":"1971","unstructured":"Epstein SE, Redwood DR, Goldstein RE, Beiser GD, Rosing DR, Glancy DL, Reis RL, Stinson EB (1971) Angina pectoris: Pathophysiology, evaluation and treatment. Ann Intern Med 75: 263\u2013296","journal-title":"Ann Intern Med"},{"issue":"Suppl 12","key":"BF02455985_CR30","first-page":"8","volume":"35","author":"PJ Richardson","year":"1981","unstructured":"Richardson PJ (1981) The pathogenetic mechanisms of angina pectoris and their relationship to the choice of antianginal treatment. Br J Clin Pract 35 [Suppl 12]: 8\u201311","journal-title":"Br J Clin Pract"},{"key":"BF02455985_CR31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0002-9149(66)90054-3","volume":"18","author":"RHE Grant","year":"1966","unstructured":"Grant RHE, Keelan P, Kernohan RJ, Leonard JC, Nancekievill L, Sinclair K (1966) Multicenter trial of propranolol in angina pectoris. Am J Cardiol 18: 361\u2013365","journal-title":"Am J Cardiol"},{"issue":"Suppl 4]","key":"BF02455985_CR32","first-page":"35","volume":"52","author":"BNC Prichard","year":"1976","unstructured":"Prichard BNC (1976) Beta-blockade in angina pectoris. Propranolol in the treatment of angina pectoris: A review. Postgrad Med J 52 [Suppl 4]: 35\u201341","journal-title":"Postgrad Med J"},{"key":"BF02455985_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(80)90361-7","volume":"68","author":"U Thadani","year":"1980","unstructured":"Thadani U, Davidson C, Singleton W, Taylor SH (1980) Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med 68: 243\u2013250","journal-title":"Am J Med"},{"key":"BF02455985_CR34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.CIR.35.6.1073","volume":"35","author":"BF Robinson","year":"1967","unstructured":"Robinson BF (1967) Relation of heart rate and systolic blood pressure on the onset of pain in angina pectoris. Circulation 35: 1073\u20131083","journal-title":"Circulation"},{"key":"BF02455985_CR35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9149(82)80013-1","volume":"49","author":"KF Hossack","year":"1982","unstructured":"Hossack KF, Pool PE, Steele P, Crawford MH, DeMaria AN, Cohen LS, Ports TA, Skalland L (1982) Efficacy of diltiazem in angina on effort: A multicenter trial. Am J Cardiol 49: 567\u2013572","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0002-9343(81)90229-1","volume":"71","author":"HS Mueller","year":"1981","unstructured":"Mueller HS, Chahine RA (1981) Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. Am J Med 71: 645\u2013657","journal-title":"Am J Med"},{"key":"BF02455985_CR37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9149(79)90202-9","volume":"44","author":"RM Moskowitz","year":"1979","unstructured":"Moskowitz RM, Piccini PA, Nacarelli GV, Zelis R (1979) Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. Am J Cardiol 44: 811\u2013816","journal-title":"Am J Cardiol"},{"key":"BF02455985_CR38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/hrt.36.10.1001","volume":"36","author":"H Tucker","year":"1974","unstructured":"Tucker H, Carson P, Bass N, Massey J (1974) Prenylamine in treatment of angina. Br Heart J 36: 1001\u20131004","journal-title":"Br Heart J"},{"key":"BF02455985_CR39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.CIR.66.3.569","volume":"66","author":"SJ Brodsky","year":"1982","unstructured":"Brodsky SJ, Cutler SS, Weiner DA, McCabe CH, Ryan TJ, Klein MD (1982) Treatment of stable angina of effort with verapamil: A double-blind, placebo controlled randomized crossover study. Circulation 66: 569\u2013574","journal-title":"Circulation"},{"key":"BF02455985_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.65.1.17","volume":"65","author":"MB Pine","year":"1982","unstructured":"Pine MB, Citron PD, Bailly DJ, Butman S, Plasencia GO, Landa DW, Wong RK (1982) Verapamil versus placebo in relieving stable angina pectoris. Circulation 65: 17\u201322","journal-title":"Circulation"},{"key":"BF02455985_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.CIR.40.4.501","volume":"40","author":"S Wolfson","year":"1969","unstructured":"Wolfson S, Gorlin R (1969) Cardiovascular pharmacology of propranolol in man. Circulation 40: 501\u2013511","journal-title":"Circulation"},{"key":"BF02455985_CR42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1378\/chest.78.1.224","volume":"78","author":"MG Bourassa","year":"1980","unstructured":"Bourassa MG, Cote P, Theroux P, Tubau JF, Genain C, Waters DD (1980) Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest 78: 224\u2013230","journal-title":"Chest"},{"key":"BF02455985_CR43","first-page":"14","volume-title":"3rd International Adalat Symposium Amsterdam","author":"P Lichtlen","year":"1976","unstructured":"Lichtlen P, Engel HJ, Amende I, Rafflenbeul W, Simon R (1976) Mechanism of various antianginal drugs. Relationship between regional flow behaviour and contractility. In: Jatene AD, Lichtlen RP (eds) 3rd International Adalat Symposium Amsterdam. Excerpta Medica, Amsterdam, pp 14\u201324"},{"key":"BF02455985_CR44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1378\/chest.78.1.216","volume":"78","author":"H Yasue","year":"1980","unstructured":"Yasue H (1980) Pathophysiology and treatment of coronary arterial spasm. Chest 78: 216\u2013223","journal-title":"Chest"},{"key":"BF02455985_CR45","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198212233072605","volume":"307","author":"E Braunwald","year":"1982","unstructured":"Braunwald E (1982) Mechanisms of action of calcium chanel blocking agents. N Engl J Med 307: 1618\u20131627","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02455985.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02455985\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02455985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:42:39Z","timestamp":1558107759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02455985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,8]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1987,8]]}},"alternative-id":["BF02455985"],"URL":"https:\/\/doi.org\/10.1007\/bf02455985","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,8]]}}}